The Alive Study: A Longitudinal Study of HIV-1 Infection in Intravenous Drug Users: Description of Methods

David Vlahov, James C. Anthony, Alvaro Muñoz, Joseph Margolick, Kenrad E. Nelson, David D. Celentano, Liza Solomon, B. Frank Polk

Research output: Contribution to journalArticlepeer-review

Abstract

To identify risk factors for infection with the human immunodeficiency virus (HIV) and for progression to the acquired immunodeficiency syndrome (AIDS) among intravenous drug users, we established a cohort in Baltimore Maryland in 1988–1989. Intravenous drug users were recruited by extensive community outreach to undergo interview and confidential HIV testing in a special study site. During 13 months of recruitment, 2,921 intravenous drug users were enrolled of whome 24 percent were HIV seropositive; 90 percent returned to receive test results. Methodological issues for enhancing recruitment and retention of drug users are discussed.

Original languageEnglish (US)
Pages (from-to)759-776
Number of pages18
JournalJournal of Drug Issues
Volume21
Issue number4
DOIs
StatePublished - Oct 1991

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Health(social science)
  • Public Health, Environmental and Occupational Health
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'The Alive Study: A Longitudinal Study of HIV-1 Infection in Intravenous Drug Users: Description of Methods'. Together they form a unique fingerprint.

Cite this